OTC Pharmaceuticals Global Industry Almanac 2016

Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Scope

Essential resource for top-line data and analysis covering the global otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

Reasons to buy

- What was the size of the global otc pharmaceuticals market by value in 2015?

- What will be the size of the global otc pharmaceuticals market in 2020?

- What factors are affecting the strength of competition in the global otc pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitors in the global otc pharmaceuticals market?

Companies mentioned

None

None

Table of Contents

EXECUTIVE SUMMARY

Market value

Market value forecast

Category segmentation

Geography segmentation

Market share

Introduction

What is this report about?

Who is the target reader?

How ...

EXECUTIVE SUMMARY

Market value

Market value forecast

Category segmentation

Geography segmentation

Market share

Introduction

What is this report about?

Who is the target reader?

How to use this report

Definitions

Global OTC Pharmaceuticals

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

OTC Pharmaceuticals in Asia-Pacific

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

OTC Pharmaceuticals in Europe

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

OTC Pharmaceuticals in France

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Germany

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Australia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Brazil

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Canada

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in China

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in India

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Indonesia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Italy

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Japan

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Mexico

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in The Netherlands

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in North America

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

OTC Pharmaceuticals in Russia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Scandinavia

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

OTC Pharmaceuticals in Singapore

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in South Africa

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in South Korea

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Spain

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in Turkey

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in The United Kingdom

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

OTC Pharmaceuticals in The United States

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Company Profiles

Leading companies

Appendix

Methodology

About MarketLine

List of Tables

Table 1: Global OTC pharmaceuticals market value: $ million, 2011–15

Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2015

Table 3: Global OTC ...

Table 1: Global OTC pharmaceuticals market value: $ million, 2011–15

Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2015

Table 3: Global OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 4: Global OTC pharmaceuticals market share: % share, by value, 2015

Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015

Table 6: Global OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 7: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011–15

Table 8: Asia–Pacific OTC pharmaceuticals market category segmentation: $ million, 2015

Table 9: Asia–Pacific OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 10: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015

Table 11: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015

Table 12: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 13: Europe OTC pharmaceuticals market value: $ million, 2011–15

Table 14: Europe OTC pharmaceuticals market category segmentation: $ million, 2015

Table 15: Europe OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 16: Europe OTC pharmaceuticals market share: % share, by value, 2015

Table 17: Europe OTC pharmaceuticals market distribution: % share, by value, 2015

Table 18: Europe OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 19: France OTC pharmaceuticals market value: $ million, 2011–15

Table 20: France OTC pharmaceuticals market category segmentation: $ million, 2015

Table 21: France OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 22: France OTC pharmaceuticals market share: % share, by value, 2015

Table 23: France OTC pharmaceuticals market distribution: % share, by value, 2015

Table 24: France OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 25: France size of population (million), 2011–15

Table 26: France gdp (constant 2005 prices, $ billion), 2011–15

Table 27: France gdp (current prices, $ billion), 2011–15

Table 28: France inflation, 2011–15

Table 29: France consumer price index (absolute), 2011–15

Table 30: France exchange rate, 2011–15

Table 31: Germany OTC pharmaceuticals market value: $ million, 2011–15

Table 32: Germany OTC pharmaceuticals market category segmentation: $ million, 2015

Table 33: Germany OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 34: Germany OTC pharmaceuticals market share: % share, by value, 2015

Table 35: Germany OTC pharmaceuticals market distribution: % share, by value, 2015

Table 36: Germany OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 37: Germany size of population (million), 2011–15

Table 38: Germany gdp (constant 2005 prices, $ billion), 2011–15

Table 39: Germany gdp (current prices, $ billion), 2011–15

Table 40: Germany inflation, 2011–15

Table 41: Germany consumer price index (absolute), 2011–15

Table 42: Germany exchange rate, 2011–15

Table 43: Australia OTC pharmaceuticals market value: $ million, 2011–15

Table 44: Australia OTC pharmaceuticals market category segmentation: $ million, 2015

Table 45: Australia OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 46: Australia OTC pharmaceuticals market share: % share, by value, 2015

Table 47: Australia OTC pharmaceuticals market distribution: % share, by value, 2015

Table 48: Australia OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 49: Australia size of population (million), 2011–15

Table 50: Australia gdp (constant 2005 prices, $ billion), 2011–15

Table 51: Australia gdp (current prices, $ billion), 2011–15

Table 52: Australia inflation, 2011–15

Table 53: Australia consumer price index (absolute), 2011–15

Table 54: Australia exchange rate, 2011–15

Table 55: Brazil OTC pharmaceuticals market value: $ million, 2011–15

Table 56: Brazil OTC pharmaceuticals market category segmentation: $ million, 2015

Table 57: Brazil OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 58: Brazil OTC pharmaceuticals market share: % share, by value, 2015

Table 59: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015

Table 60: Brazil OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 61: Brazil size of population (million), 2011–15

Table 62: Brazil gdp (constant 2005 prices, $ billion), 2011–15

Table 63: Brazil gdp (current prices, $ billion), 2011–15

Table 64: Brazil inflation, 2011–15

Table 65: Brazil consumer price index (absolute), 2011–15

Table 66: Brazil exchange rate, 2011–15

Table 67: Canada OTC pharmaceuticals market value: $ million, 2011–15

Table 68: Canada OTC pharmaceuticals market category segmentation: $ million, 2015

Table 69: Canada OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 70: Canada OTC pharmaceuticals market share: % share, by value, 2015

Table 71: Canada OTC pharmaceuticals market distribution: % share, by value, 2015

Table 72: Canada OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 73: Canada size of population (million), 2011–15

Table 74: Canada gdp (constant 2005 prices, $ billion), 2011–15

Table 75: Canada gdp (current prices, $ billion), 2011–15

Table 76: Canada inflation, 2011–15

Table 77: Canada consumer price index (absolute), 2011–15

Table 78: Canada exchange rate, 2011–15

Table 79: China OTC pharmaceuticals market value: $ million, 2011–15

Table 80: China OTC pharmaceuticals market category segmentation: $ million, 2015

Table 81: China OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 82: China OTC pharmaceuticals market share: % share, by value, 2015

Table 83: China OTC pharmaceuticals market distribution: % share, by value, 2015

Table 84: China OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 85: China size of population (million), 2011–15

Table 86: China gdp (constant 2005 prices, $ billion), 2011–15

Table 87: China gdp (current prices, $ billion), 2011–15

Table 88: China inflation, 2011–15

Table 89: China consumer price index (absolute), 2011–15

Table 90: China exchange rate, 2011–15

Table 91: India OTC pharmaceuticals market value: $ million, 2011–15

Table 92: India OTC pharmaceuticals market category segmentation: $ million, 2015

Table 93: India OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 94: India OTC pharmaceuticals market share: % share, by value, 2015

Table 95: India OTC pharmaceuticals market distribution: % share, by value, 2015

Table 96: India OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 97: India size of population (million), 2011–15

Table 98: India gdp (constant 2005 prices, $ billion), 2011–15

Table 99: India gdp (current prices, $ billion), 2011–15

Table 100: India inflation, 2011–15

Table 101: India consumer price index (absolute), 2011–15

Table 102: India exchange rate, 2011–15

Table 103: Indonesia OTC pharmaceuticals market value: $ million, 2011–15

Table 104: Indonesia OTC pharmaceuticals market category segmentation: $ million, 2015

Table 105: Indonesia OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 106: Indonesia OTC pharmaceuticals market share: % share, by value, 2015

Table 107: Indonesia OTC pharmaceuticals market distribution: % share, by value, 2015

Table 108: Indonesia OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 109: Indonesia size of population (million), 2011–15

Table 110: Indonesia gdp (constant 2005 prices, $ billion), 2011–15

Table 111: Indonesia gdp (current prices, $ billion), 2011–15

Table 112: Indonesia inflation, 2011–15

Table 113: Indonesia consumer price index (absolute), 2011–15

Table 114: Indonesia exchange rate, 2011–15

Table 115: Italy OTC pharmaceuticals market value: $ million, 2011–15

Table 116: Italy OTC pharmaceuticals market category segmentation: $ million, 2015

Table 117: Italy OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 118: Italy OTC pharmaceuticals market share: % share, by value, 2015

Table 119: Italy OTC pharmaceuticals market distribution: % share, by value, 2015

Table 120: Italy OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 121: Italy size of population (million), 2011–15

Table 122: Italy gdp (constant 2005 prices, $ billion), 2011–15

Table 123: Italy gdp (current prices, $ billion), 2011–15

Table 124: Italy inflation, 2011–15

Table 125: Italy consumer price index (absolute), 2011–15

Table 126: Italy exchange rate, 2011–15

Table 127: Japan OTC pharmaceuticals market value: $ million, 2011–15

Table 128: Japan OTC pharmaceuticals market category segmentation: $ million, 2015

Table 129: Japan OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 130: Japan OTC pharmaceuticals market share: % share, by value, 2015

Table 131: Japan OTC pharmaceuticals market distribution: % share, by value, 2015

Table 132: Japan OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 133: Japan size of population (million), 2011–15

Table 134: Japan gdp (constant 2005 prices, $ billion), 2011–15

Table 135: Japan gdp (current prices, $ billion), 2011–15

Table 136: Japan inflation, 2011–15

Table 137: Japan consumer price index (absolute), 2011–15

Table 138: Japan exchange rate, 2011–15

Table 139: Mexico OTC pharmaceuticals market value: $ million, 2011–15

Table 140: Mexico OTC pharmaceuticals market category segmentation: $ million, 2015

Table 141: Mexico OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 142: Mexico OTC pharmaceuticals market share: % share, by value, 2015

Table 143: Mexico OTC pharmaceuticals market distribution: % share, by value, 2015

Table 144: Mexico OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 145: Mexico size of population (million), 2011–15

Table 146: Mexico gdp (constant 2005 prices, $ billion), 2011–15

Table 147: Mexico gdp (current prices, $ billion), 2011–15

Table 148: Mexico inflation, 2011–15

Table 149: Mexico consumer price index (absolute), 2011–15

Table 150: Mexico exchange rate, 2011–15

Table 151: Netherlands OTC pharmaceuticals market value: $ million, 2011–15

Table 152: Netherlands OTC pharmaceuticals market category segmentation: $ million, 2015

Table 153: Netherlands OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 154: Netherlands OTC pharmaceuticals market share: % share, by value, 2015

Table 155: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015

Table 156: Netherlands OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 157: Netherlands size of population (million), 2011–15

Table 158: Netherlands gdp (constant 2005 prices, $ billion), 2011–15

Table 159: Netherlands gdp (current prices, $ billion), 2011–15

Table 160: Netherlands inflation, 2011–15

Table 161: Netherlands consumer price index (absolute), 2011–15

Table 162: Netherlands exchange rate, 2011–15

Table 163: North America OTC pharmaceuticals market value: $ million, 2011–15

Table 164: North America OTC pharmaceuticals market category segmentation: $ million, 2015

Table 165: North America OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 166: North America OTC pharmaceuticals market share: % share, by value, 2015

Table 167: North America OTC pharmaceuticals market distribution: % share, by value, 2015

Table 168: North America OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 169: Russia OTC pharmaceuticals market value: $ million, 2011–15

Table 170: Russia OTC pharmaceuticals market category segmentation: $ million, 2015

Table 171: Russia OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 172: Russia OTC pharmaceuticals market share: % share, by value, 2015

Table 173: Russia OTC pharmaceuticals market distribution: % share, by value, 2015

Table 174: Russia OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 175: Russia size of population (million), 2011–15

Table 176: Russia gdp (constant 2005 prices, $ billion), 2011–15

Table 177: Russia gdp (current prices, $ billion), 2011–15

Table 178: Russia inflation, 2011–15

Table 179: Russia consumer price index (absolute), 2011–15

Table 180: Russia exchange rate, 2011–15

Table 181: Scandinavia OTC pharmaceuticals market value: $ million, 2011–15

Table 182: Scandinavia OTC pharmaceuticals market category segmentation: $ million, 2015

Table 183: Scandinavia OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 184: Scandinavia OTC pharmaceuticals market share: % share, by value, 2015

Table 185: Scandinavia OTC pharmaceuticals market distribution: % share, by value, 2015

Table 186: Scandinavia OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 187: Singapore OTC pharmaceuticals market value: $ million, 2011–15

Table 188: Singapore OTC pharmaceuticals market category segmentation: $ million, 2015

Table 189: Singapore OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 190: Singapore OTC pharmaceuticals market share: % share, by value, 2015

Table 191: Singapore OTC pharmaceuticals market distribution: % share, by value, 2015

Table 192: Singapore OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 193: Singapore size of population (million), 2011–15

Table 194: Singapore gdp (constant 2005 prices, $ billion), 2011–15

Table 195: Singapore gdp (current prices, $ billion), 2011–15

Table 196: Singapore inflation, 2011–15

Table 197: Singapore consumer price index (absolute), 2011–15

Table 198: Singapore exchange rate, 2011–15

Table 199: South Africa OTC pharmaceuticals market value: $ million, 2011–15

Table 200: South Africa OTC pharmaceuticals market category segmentation: $ million, 2015

Table 201: South Africa OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 202: South Africa OTC pharmaceuticals market share: % share, by value, 2015

Table 203: South Africa OTC pharmaceuticals market distribution: % share, by value, 2015

Table 204: South Africa OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 205: South Africa size of population (million), 2011–15

Table 206: South Africa gdp (constant 2005 prices, $ billion), 2011–15

Table 207: South Africa gdp (current prices, $ billion), 2011–15

Table 208: South Africa inflation, 2011–15

Table 209: South Africa consumer price index (absolute), 2011–15

Table 210: South Africa exchange rate, 2011–15

Table 211: South Korea OTC pharmaceuticals market value: $ million, 2011–15

Table 212: South Korea OTC pharmaceuticals market category segmentation: $ million, 2015

Table 213: South Korea OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 214: South Korea OTC pharmaceuticals market share: % share, by value, 2015

Table 215: South Korea OTC pharmaceuticals market distribution: % share, by value, 2015

Table 216: South Korea OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 217: South Korea size of population (million), 2011–15

Table 218: South Korea gdp (constant 2005 prices, $ billion), 2011–15

Table 219: South Korea gdp (current prices, $ billion), 2011–15

Table 220: South Korea inflation, 2011–15

Table 221: South Korea consumer price index (absolute), 2011–15

Table 222: South Korea exchange rate, 2011–15

Table 223: Spain OTC pharmaceuticals market value: $ million, 2011–15

Table 224: Spain OTC pharmaceuticals market category segmentation: $ million, 2015

Table 225: Spain OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 226: Spain OTC pharmaceuticals market share: % share, by value, 2015

Table 227: Spain OTC pharmaceuticals market distribution: % share, by value, 2015

Table 228: Spain OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 229: Spain size of population (million), 2011–15

Table 230: Spain gdp (constant 2005 prices, $ billion), 2011–15

Table 231: Spain gdp (current prices, $ billion), 2011–15

Table 232: Spain inflation, 2011–15

Table 233: Spain consumer price index (absolute), 2011–15

Table 234: Spain exchange rate, 2011–15

Table 235: Turkey OTC pharmaceuticals market value: $ million, 2011–15

Table 236: Turkey OTC pharmaceuticals market category segmentation: $ million, 2015

Table 237: Turkey OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 238: Turkey OTC pharmaceuticals market share: % share, by value, 2015

Table 239: Turkey OTC pharmaceuticals market distribution: % share, by value, 2015

Table 240: Turkey OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 241: Turkey size of population (million), 2011–15

Table 242: Turkey gdp (constant 2005 prices, $ billion), 2011–15

Table 243: Turkey gdp (current prices, $ billion), 2011–15

Table 244: Turkey inflation, 2011–15

Table 245: Turkey consumer price index (absolute), 2011–15

Table 246: Turkey exchange rate, 2011–15

Table 247: United Kingdom OTC pharmaceuticals market value: $ million, 2011–15

Table 248: United Kingdom OTC pharmaceuticals market category segmentation: $ million, 2015

Table 249: United Kingdom OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 250: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015

Table 251: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015

Table 252: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 253: United Kingdom size of population (million), 2011–15

Table 254: United Kingdom gdp (constant 2005 prices, $ billion), 2011–15

Table 255: United Kingdom gdp (current prices, $ billion), 2011–15

Table 256: United Kingdom inflation, 2011–15

Table 257: United Kingdom consumer price index (absolute), 2011–15

Table 258: United Kingdom exchange rate, 2011–15

Table 259: United States OTC pharmaceuticals market value: $ million, 2011–15

Table 260: United States OTC pharmaceuticals market category segmentation: $ million, 2015

Table 261: United States OTC pharmaceuticals market geography segmentation: $ million, 2015

Table 262: United States OTC pharmaceuticals market share: % share, by value, 2015

Table 263: United States OTC pharmaceuticals market distribution: % share, by value, 2015

Table 264: United States OTC pharmaceuticals market value forecast: $ million, 2015–20

Table 265: United States size of population (million), 2011–15

Table 266: United States gdp (constant 2005 prices, $ billion), 2011–15

Table 267: United States gdp (current prices, $ billion), 2011–15

Table 268: United States inflation, 2011–15

Table 269: United States consumer price index (absolute), 2011–15

Table 270: United States exchange rate, 2011–15

Table 271: Bayer AG: key facts

Table 272: Bayer AG: key financials ($)

Table 273: Bayer AG: key financials (€)

Table 274: Bayer AG: key financial ratios

Table 275: GlaxoSmithKline Plc: key facts

Table 276: GlaxoSmithKline Plc: key financials ($)

Table 277: GlaxoSmithKline Plc: key financials (£)

Table 278: GlaxoSmithKline Plc: key financial ratios

Table 279: Johnson & Johnson: key facts

Table 280: Johnson & Johnson: key financials ($)

Table 281: Johnson & Johnson: key financial ratios

Table 282: Novartis AG: key facts

Table 283: Novartis AG: key financials ($)

Table 284: Novartis AG: key financial ratios

Table 285: Nin Jiom Medicines Manufactory Ltd: key facts

Table 286: The Procter & Gamble Company: key facts

Table 287: The Procter & Gamble Company: key financials ($)

Table 288: The Procter & Gamble Company: key financial ratios

Table 289: Reckitt Benckiser Group plc: key facts

Table 290: Reckitt Benckiser Group plc: key financials ($)

Table 291: Reckitt Benckiser Group plc: key financials (£)

Table 292: Reckitt Benckiser Group plc: key financial ratios

Table 293: Sanofi SA: key facts

Table 294: Sanofi SA: key financials ($)

Table 295: Sanofi SA: key financials (€)

Table 296: Sanofi SA: key financial ratios

Table 297: Almirall S.A.: key facts

Table 298: Almirall S.A.: key financials ($)

Table 299: Almirall S.A.: key financials (€)

Table 300: Almirall S.A.: key financial ratios

Table 301: Pfizer Inc.: key facts

Table 302: Pfizer Inc.: key financials ($)

Table 303: Pfizer Inc.: key financial ratios

Table 304: Suntory Group: key facts

Table 305: Suntory Group: key financials ($)

Table 306: Suntory Group: key financials (¥)

Table 307: Suntory Group: key financial ratios

Table 308: Abbott Laboratories: key facts

Table 309: Abbott Laboratories: key financials ($)

Table 310: Abbott Laboratories: key financial ratios

Table 311: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts

Table 312: Cipla Limited: key facts

Table 313: Cipla Limited: key financials ($)

Table 314: Cipla Limited: key financials (Rs.)

Table 315: Cipla Limited: key financial ratios

Table 316: Dabur India Limited: key facts

Table 317: Dabur India Limited: key financials ($)

Table 318: Dabur India Limited: key financials (Rs.)

Table 319: Dabur India Limited: key financial ratios

Table 320: Darya-Varia Laboratoria Tbk: key facts

Table 321: Darya-Varia Laboratoria Tbk: key financials ($)

Table 322: Darya-Varia Laboratoria Tbk: key financials (IDR)

Table 323: Darya-Varia Laboratoria Tbk: key financial ratios

Table 324: PT Kalbe Farma Tbk: key facts

Table 325: PT Kalbe Farma Tbk: key financials ($)

Table 326: PT Kalbe Farma Tbk: key financials (IDR)

Table 327: PT Kalbe Farma Tbk: key financial ratios

Table 328: Boehringer Ingelheim GmbH: key facts

Table 329: Boehringer Ingelheim GmbH: key financials ($)

Table 330: Boehringer Ingelheim GmbH: key financials (€)

Table 331: Boehringer Ingelheim GmbH: key financial ratios

Table 332: Daiichi Sankyo Co., Ltd.: key facts

Table 333: Daiichi Sankyo Co., Ltd.: key financials ($)

Table 334: Daiichi Sankyo Co., Ltd.: key financials (¥)

Table 335: Daiichi Sankyo Co., Ltd.: key financial ratios

Table 336: Kracie Holdings, Ltd.: key facts

Table 337: Bristol Myers Squibb Company: key facts

Table 338: Bristol Myers Squibb Company: key financials ($)

Table 339: Bristol Myers Squibb Company: key financial ratios

Table 340: Royal DSM N.V.: key facts

Table 341: Royal DSM N.V.: key financials ($)

Table 342: Royal DSM N.V.: key financials (€)

Table 343: Royal DSM N.V.: key financial ratios

Table 344: JSC ELFA: key facts

Table 345: The Menarini Group: key facts

Table 346: The Menarini Group: key financials ($)

Table 347: The Menarini Group: key financials (€)

Table 348: The Menarini Group: key financial ratios

Table 349: Pharmstandard OJSC: key facts

Table 350: Pharmstandard OJSC: key financials ($)

Table 351: Pharmstandard OJSC: key financials (RUB)

Table 352: Pharmstandard OJSC: key financial ratios

Table 353: Eu Yan Sang International Ltd.: key facts

Table 354: Eu Yan Sang International Ltd.: key financials ($)

Table 355: Eu Yan Sang International Ltd.: key financials (Si$)

Table 356: Eu Yan Sang International Ltd.: key financial ratios

Table 357: Adcock Ingram Holdings Limited: key facts

Table 358: Adcock Ingram Holdings Limited: key financials ($)

Table 359: Adcock Ingram Holdings Limited: key financials (ZAR)

Table 360: Adcock Ingram Holdings Limited: key financial ratios

Table 361: Pharma Natura (Pty) Ltd.: key facts

Table 362: Weleda AG: key facts

Table 363: Boryung Pharm Co., Ltd.: key facts

Table 364: Boryung Pharm Co., Ltd.: key financials ($)

Table 365: Boryung Pharm Co., Ltd.: key financials (KRW)

Table 366: Boryung Pharm Co., Ltd.: key financial ratios

Table 367: Dongwha Pharm Co., Ltd.: key facts

Table 368: Whanin Pharmaceutical Co., Ltd.: key facts

Table 369: Whanin Pharmaceutical Co., Ltd.: key financials ($)

Table 370: Whanin Pharmaceutical Co., Ltd.: key financials (KRW)

Table 371: Whanin Pharmaceutical Co., Ltd.: key financial ratios

Table 372: Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.: key facts

Table 373: Nobel Ilac San ve Tic A.S.: key facts

List of Figures

Figure 1: Global OTC pharmaceuticals market value: $ million, 2011–15

Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 3: ...

Figure 1: Global OTC pharmaceuticals market value: $ million, 2011–15

Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 3: Global OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 4: Global OTC pharmaceuticals market share: % share, by value, 2015

Figure 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 6: Global OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 7: Forces driving competition in the global OTC pharmaceuticals market, 2015

Figure 8: Drivers of buyer power in the global OTC pharmaceuticals market, 2015

Figure 9: Drivers of supplier power in the global OTC pharmaceuticals market, 2015

Figure 10: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2015

Figure 11: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2015

Figure 12: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2015

Figure 13: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011–15

Figure 14: Asia–Pacific OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 15: Asia–Pacific OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 16: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015

Figure 17: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 18: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 19: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 20: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 21: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 22: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 23: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 24: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2015

Figure 25: Europe OTC pharmaceuticals market value: $ million, 2011–15

Figure 26: Europe OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 27: Europe OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 28: Europe OTC pharmaceuticals market share: % share, by value, 2015

Figure 29: Europe OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 30: Europe OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 31: Forces driving competition in the OTC pharmaceuticals market in Europe, 2015

Figure 32: Drivers of buyer power in the OTC pharmaceuticals market in Europe, 2015

Figure 33: Drivers of supplier power in the OTC pharmaceuticals market in Europe, 2015

Figure 34: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Europe, 2015

Figure 35: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Europe, 2015

Figure 36: Drivers of degree of rivalry in the OTC pharmaceuticals market in Europe, 2015

Figure 37: France OTC pharmaceuticals market value: $ million, 2011–15

Figure 38: France OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 39: France OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 40: France OTC pharmaceuticals market share: % share, by value, 2015

Figure 41: France OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 42: France OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 43: Forces driving competition in the OTC pharmaceuticals market in France, 2015

Figure 44: Drivers of buyer power in the OTC pharmaceuticals market in France, 2015

Figure 45: Drivers of supplier power in the OTC pharmaceuticals market in France, 2015

Figure 46: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in France, 2015

Figure 47: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in France, 2015

Figure 48: Drivers of degree of rivalry in the OTC pharmaceuticals market in France, 2015

Figure 49: Germany OTC pharmaceuticals market value: $ million, 2011–15

Figure 50: Germany OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 51: Germany OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 52: Germany OTC pharmaceuticals market share: % share, by value, 2015

Figure 53: Germany OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 54: Germany OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 55: Forces driving competition in the OTC pharmaceuticals market in Germany, 2015

Figure 56: Drivers of buyer power in the OTC pharmaceuticals market in Germany, 2015

Figure 57: Drivers of supplier power in the OTC pharmaceuticals market in Germany, 2015

Figure 58: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Germany, 2015

Figure 59: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Germany, 2015

Figure 60: Drivers of degree of rivalry in the OTC pharmaceuticals market in Germany, 2015

Figure 61: Australia OTC pharmaceuticals market value: $ million, 2011–15

Figure 62: Australia OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 63: Australia OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 64: Australia OTC pharmaceuticals market share: % share, by value, 2015

Figure 65: Australia OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 66: Australia OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 67: Forces driving competition in the OTC pharmaceuticals market in Australia, 2015

Figure 68: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2015

Figure 69: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2015

Figure 70: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2015

Figure 71: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2015

Figure 72: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2015

Figure 73: Brazil OTC pharmaceuticals market value: $ million, 2011–15

Figure 74: Brazil OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 75: Brazil OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 76: Brazil OTC pharmaceuticals market share: % share, by value, 2015

Figure 77: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 78: Brazil OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 79: Forces driving competition in the OTC pharmaceuticals market in Brazil, 2015

Figure 80: Drivers of buyer power in the OTC pharmaceuticals market in Brazil, 2015

Figure 81: Drivers of supplier power in the OTC pharmaceuticals market in Brazil, 2015

Figure 82: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Brazil, 2015

Figure 83: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Brazil, 2015

Figure 84: Drivers of degree of rivalry in the OTC pharmaceuticals market in Brazil, 2015

Figure 85: Canada OTC pharmaceuticals market value: $ million, 2011–15

Figure 86: Canada OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 87: Canada OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 88: Canada OTC pharmaceuticals market share: % share, by value, 2015

Figure 89: Canada OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 90: Canada OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 91: Forces driving competition in the OTC pharmaceuticals market in Canada, 2015

Figure 92: Drivers of buyer power in the OTC pharmaceuticals market in Canada, 2015

Figure 93: Drivers of supplier power in the OTC pharmaceuticals market in Canada, 2015

Figure 94: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Canada, 2015

Figure 95: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Canada, 2015

Figure 96: Drivers of degree of rivalry in the OTC pharmaceuticals market in Canada, 2015

Figure 97: China OTC pharmaceuticals market value: $ million, 2011–15

Figure 98: China OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 99: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 100: China OTC pharmaceuticals market share: % share, by value, 2015

Figure 101: China OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 102: China OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 103: Forces driving competition in the OTC pharmaceuticals market in China, 2015

Figure 104: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015

Figure 105: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015

Figure 106: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015

Figure 107: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015

Figure 108: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015

Figure 109: India OTC pharmaceuticals market value: $ million, 2011–15

Figure 110: India OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 111: India OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 112: India OTC pharmaceuticals market share: % share, by value, 2015

Figure 113: India OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 114: India OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 115: Forces driving competition in the OTC pharmaceuticals market in India, 2015

Figure 116: Drivers of buyer power in the OTC pharmaceuticals market in India, 2015

Figure 117: Drivers of supplier power in the OTC pharmaceuticals market in India, 2015

Figure 118: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in India, 2015

Figure 119: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in India, 2015

Figure 120: Drivers of degree of rivalry in the OTC pharmaceuticals market in India, 2015

Figure 121: Indonesia OTC pharmaceuticals market value: $ million, 2011–15

Figure 122: Indonesia OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 123: Indonesia OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 124: Indonesia OTC pharmaceuticals market share: % share, by value, 2015

Figure 125: Indonesia OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 126: Indonesia OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 127: Forces driving competition in the OTC pharmaceuticals market in Indonesia, 2015

Figure 128: Drivers of buyer power in the OTC pharmaceuticals market in Indonesia, 2015

Figure 129: Drivers of supplier power in the OTC pharmaceuticals market in Indonesia, 2015

Figure 130: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Indonesia, 2015

Figure 131: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Indonesia, 2015

Figure 132: Drivers of degree of rivalry in the OTC pharmaceuticals market in Indonesia, 2015

Figure 133: Italy OTC pharmaceuticals market value: $ million, 2011–15

Figure 134: Italy OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 135: Italy OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 136: Italy OTC pharmaceuticals market share: % share, by value, 2015

Figure 137: Italy OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 138: Italy OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 139: Forces driving competition in the OTC pharmaceuticals market in Italy, 2015

Figure 140: Drivers of buyer power in the OTC pharmaceuticals market in Italy, 2015

Figure 141: Drivers of supplier power in the OTC pharmaceuticals market in Italy, 2015

Figure 142: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Italy, 2015

Figure 143: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Italy, 2015

Figure 144: Drivers of degree of rivalry in the OTC pharmaceuticals market in Italy, 2015

Figure 145: Japan OTC pharmaceuticals market value: $ million, 2011–15

Figure 146: Japan OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 147: Japan OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 148: Japan OTC pharmaceuticals market share: % share, by value, 2015

Figure 149: Japan OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 150: Japan OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 151: Forces driving competition in the OTC pharmaceuticals market in Japan, 2015

Figure 152: Drivers of buyer power in the OTC pharmaceuticals market in Japan, 2015

Figure 153: Drivers of supplier power in the OTC pharmaceuticals market in Japan, 2015

Figure 154: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Japan, 2015

Figure 155: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Japan, 2015

Figure 156: Drivers of degree of rivalry in the OTC pharmaceuticals market in Japan, 2015

Figure 157: Mexico OTC pharmaceuticals market value: $ million, 2011–15

Figure 158: Mexico OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 159: Mexico OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 160: Mexico OTC pharmaceuticals market share: % share, by value, 2015

Figure 161: Mexico OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 162: Mexico OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 163: Forces driving competition in the OTC pharmaceuticals market in Mexico, 2015

Figure 164: Drivers of buyer power in the OTC pharmaceuticals market in Mexico, 2015

Figure 165: Drivers of supplier power in the OTC pharmaceuticals market in Mexico, 2015

Figure 166: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Mexico, 2015

Figure 167: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Mexico, 2015

Figure 168: Drivers of degree of rivalry in the OTC pharmaceuticals market in Mexico, 2015

Figure 169: Netherlands OTC pharmaceuticals market value: $ million, 2011–15

Figure 170: Netherlands OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 171: Netherlands OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 172: Netherlands OTC pharmaceuticals market share: % share, by value, 2015

Figure 173: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 174: Netherlands OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 175: Forces driving competition in the OTC pharmaceuticals market in the Netherlands, 2015

Figure 176: Drivers of buyer power in the OTC pharmaceuticals market in the Netherlands, 2015

Figure 177: Drivers of supplier power in the OTC pharmaceuticals market in the Netherlands, 2015

Figure 178: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the Netherlands, 2015

Figure 179: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the Netherlands, 2015

Figure 180: Drivers of degree of rivalry in the OTC pharmaceuticals market in the Netherlands, 2015

Figure 181: North America OTC pharmaceuticals market value: $ million, 2011–15

Figure 182: North America OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 183: North America OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 184: North America OTC pharmaceuticals market share: % share, by value, 2015

Figure 185: North America OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 186: North America OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 187: Forces driving competition in the OTC pharmaceuticals market in North America, 2015

Figure 188: Drivers of buyer power in the OTC pharmaceuticals market in North America, 2015

Figure 189: Drivers of supplier power in the OTC pharmaceuticals market in North America, 2015

Figure 190: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in North America, 2015

Figure 191: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in North America, 2015

Figure 192: Drivers of degree of rivalry in the OTC pharmaceuticals market in North America, 2015

Figure 193: Russia OTC pharmaceuticals market value: $ million, 2011–15

Figure 194: Russia OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 195: Russia OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 196: Russia OTC pharmaceuticals market share: % share, by value, 2015

Figure 197: Russia OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 198: Russia OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 199: Forces driving competition in the OTC pharmaceuticals market in Russia, 2015

Figure 200: Drivers of buyer power in the OTC pharmaceuticals market in Russia, 2015

Figure 201: Drivers of supplier power in the OTC pharmaceuticals market in Russia, 2015

Figure 202: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Russia, 2015

Figure 203: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Russia, 2015

Figure 204: Drivers of degree of rivalry in the OTC pharmaceuticals market in Russia, 2015

Figure 205: Scandinavia OTC pharmaceuticals market value: $ million, 2011–15

Figure 206: Scandinavia OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 207: Scandinavia OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 208: Scandinavia OTC pharmaceuticals market share: % share, by value, 2015

Figure 209: Scandinavia OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 210: Scandinavia OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 211: Forces driving competition in the OTC pharmaceuticals market in Scandinavia, 2015

Figure 212: Drivers of buyer power in the OTC pharmaceuticals market in Scandinavia, 2015

Figure 213: Drivers of supplier power in the OTC pharmaceuticals market in Scandinavia, 2015

Figure 214: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Scandinavia, 2015

Figure 215: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Scandinavia, 2015

Figure 216: Drivers of degree of rivalry in the OTC pharmaceuticals market in Scandinavia, 2015

Figure 217: Singapore OTC pharmaceuticals market value: $ million, 2011–15

Figure 218: Singapore OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 219: Singapore OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 220: Singapore OTC pharmaceuticals market share: % share, by value, 2015

Figure 221: Singapore OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 222: Singapore OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 223: Forces driving competition in the OTC pharmaceuticals market in Singapore, 2015

Figure 224: Drivers of buyer power in the OTC pharmaceuticals market in Singapore, 2015

Figure 225: Drivers of supplier power in the OTC pharmaceuticals market in Singapore, 2015

Figure 226: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Singapore, 2015

Figure 227: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Singapore, 2015

Figure 228: Drivers of degree of rivalry in the OTC pharmaceuticals market in Singapore, 2015

Figure 229: South Africa OTC pharmaceuticals market value: $ million, 2011–15

Figure 230: South Africa OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 231: South Africa OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 232: South Africa OTC pharmaceuticals market share: % share, by value, 2015

Figure 233: South Africa OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 234: South Africa OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 235: Forces driving competition in the OTC pharmaceuticals market in South Africa, 2015

Figure 236: Drivers of buyer power in the OTC pharmaceuticals market in South Africa, 2015

Figure 237: Drivers of supplier power in the OTC pharmaceuticals market in South Africa, 2015

Figure 238: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Africa, 2015

Figure 239: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Africa, 2015

Figure 240: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Africa, 2015

Figure 241: South Korea OTC pharmaceuticals market value: $ million, 2011–15

Figure 242: South Korea OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 243: South Korea OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 244: South Korea OTC pharmaceuticals market share: % share, by value, 2015

Figure 245: South Korea OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 246: South Korea OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 247: Forces driving competition in the OTC pharmaceuticals market in South Korea, 2015

Figure 248: Drivers of buyer power in the OTC pharmaceuticals market in South Korea, 2015

Figure 249: Drivers of supplier power in the OTC pharmaceuticals market in South Korea, 2015

Figure 250: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Korea, 2015

Figure 251: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Korea, 2015

Figure 252: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Korea, 2015

Figure 253: Spain OTC pharmaceuticals market value: $ million, 2011–15

Figure 254: Spain OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 255: Spain OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 256: Spain OTC pharmaceuticals market share: % share, by value, 2015

Figure 257: Spain OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 258: Spain OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 259: Forces driving competition in the OTC pharmaceuticals market in Spain, 2015

Figure 260: Drivers of buyer power in the OTC pharmaceuticals market in Spain, 2015

Figure 261: Drivers of supplier power in the OTC pharmaceuticals market in Spain, 2015

Figure 262: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Spain, 2015

Figure 263: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Spain, 2015

Figure 264: Drivers of degree of rivalry in the OTC pharmaceuticals market in Spain, 2015

Figure 265: Turkey OTC pharmaceuticals market value: $ million, 2011–15

Figure 266: Turkey OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 267: Turkey OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 268: Turkey OTC pharmaceuticals market share: % share, by value, 2015

Figure 269: Turkey OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 270: Turkey OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 271: Forces driving competition in the OTC pharmaceuticals market in Turkey, 2015

Figure 272: Drivers of buyer power in the OTC pharmaceuticals market in Turkey, 2015

Figure 273: Drivers of supplier power in the OTC pharmaceuticals market in Turkey, 2015

Figure 274: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Turkey, 2015

Figure 275: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Turkey, 2015

Figure 276: Drivers of degree of rivalry in the OTC pharmaceuticals market in Turkey, 2015

Figure 277: United Kingdom OTC pharmaceuticals market value: $ million, 2011–15

Figure 278: United Kingdom OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 279: United Kingdom OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 280: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015

Figure 281: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 282: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 283: Forces driving competition in the OTC pharmaceuticals market in the United Kingdom, 2015

Figure 284: Drivers of buyer power in the OTC pharmaceuticals market in the United Kingdom, 2015

Figure 285: Drivers of supplier power in the OTC pharmaceuticals market in the United Kingdom, 2015

Figure 286: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United Kingdom, 2015

Figure 287: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United Kingdom, 2015

Figure 288: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United Kingdom, 2015

Figure 289: United States OTC pharmaceuticals market value: $ million, 2011–15

Figure 290: United States OTC pharmaceuticals market category segmentation: % share, by value, 2015

Figure 291: United States OTC pharmaceuticals market geography segmentation: % share, by value, 2015

Figure 292: United States OTC pharmaceuticals market share: % share, by value, 2015

Figure 293: United States OTC pharmaceuticals market distribution: % share, by value, 2015

Figure 294: United States OTC pharmaceuticals market value forecast: $ million, 2015–20

Figure 295: Forces driving competition in the OTC pharmaceuticals market in the United States, 2015

Figure 296: Drivers of buyer power in the OTC pharmaceuticals market in the United States, 2015

Figure 297: Drivers of supplier power in the OTC pharmaceuticals market in the United States, 2015

Figure 298: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United States, 2015

Figure 299: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United States, 2015

Figure 300: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United States, 2015

Figure 301: Bayer AG: revenues & profitability

Figure 302: Bayer AG: assets & liabilities

Figure 303: GlaxoSmithKline Plc: revenues & profitability

Figure 304: GlaxoSmithKline Plc: assets & liabilities

Figure 305: Johnson & Johnson: revenues & profitability

Figure 306: Johnson & Johnson: assets & liabilities

Figure 307: Novartis AG: revenues & profitability

Figure 308: Novartis AG: assets & liabilities

Figure 309: The Procter & Gamble Company: revenues & profitability

Figure 310: The Procter & Gamble Company: assets & liabilities

Figure 311: Reckitt Benckiser Group plc: revenues & profitability

Figure 312: Reckitt Benckiser Group plc: assets & liabilities

Figure 313: Sanofi SA: revenues & profitability

Figure 314: Sanofi SA: assets & liabilities

Figure 315: Almirall S.A.: revenues & profitability

Figure 316: Almirall S.A.: assets & liabilities

Figure 317: Pfizer Inc.: revenues & profitability

Figure 318: Pfizer Inc.: assets & liabilities

Figure 319: Suntory Group: revenues & profitability

Figure 320: Suntory Group: assets & liabilities

Figure 321: Abbott Laboratories: revenues & profitability

Figure 322: Abbott Laboratories: assets & liabilities

Figure 323: Cipla Limited: revenues & profitability

Figure 324: Cipla Limited: assets & liabilities

Figure 325: Dabur India Limited: revenues & profitability

Figure 326: Dabur India Limited: assets & liabilities

Figure 327: Darya-Varia Laboratoria Tbk: revenues & profitability

Figure 328: Darya-Varia Laboratoria Tbk: assets & liabilities

Figure 329: PT Kalbe Farma Tbk: revenues & profitability

Figure 330: PT Kalbe Farma Tbk: assets & liabilities

Figure 331: Boehringer Ingelheim GmbH: revenues & profitability

Figure 332: Boehringer Ingelheim GmbH: assets & liabilities

Figure 333: Daiichi Sankyo Co., Ltd.: revenues & profitability

Figure 334: Daiichi Sankyo Co., Ltd.: assets & liabilities

Figure 335: Bristol Myers Squibb Company: revenues & profitability

Figure 336: Bristol Myers Squibb Company: assets & liabilities

Figure 337: Royal DSM N.V.: revenues & profitability

Figure 338: Royal DSM N.V.: assets & liabilities

Figure 339: Pharmstandard OJSC: revenues & profitability

Figure 340: Pharmstandard OJSC: assets & liabilities

Figure 341: Eu Yan Sang International Ltd.: revenues & profitability

Figure 342: Eu Yan Sang International Ltd.: assets & liabilities

Figure 343: Adcock Ingram Holdings Limited: revenues & profitability

Figure 344: Adcock Ingram Holdings Limited: assets & liabilities

Figure 345: Boryung Pharm Co., Ltd.: revenues & profitability

Figure 346: Boryung Pharm Co., Ltd.: assets & liabilities

Figure 347: Whanin Pharmaceutical Co., Ltd.: revenues & profitability

Figure 348: Whanin Pharmaceutical Co., Ltd.: assets & liabilities

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports